600 eczema patients to be watched in french Real-World treatment study
NCT ID NCT06837454
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 600 adults with moderate-to-severe atopic dermatitis (eczema) who are eligible for or already taking systemic medications. Researchers will track which treatments are used, how long patients stay on them, and how well they follow their regimen. The goal is to understand real-world treatment patterns, not to test a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 600 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients participating in this study will be more than equal to (≥) 18 years old, managed in France for moderate to severe AD, and who are either eligible to systemic treatment or currently under systemic treatment, in realworldsettings within the inclusion period.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Signed informed consent form. * Patient with moderate to severe AD according to the Investigator's judgment and 1. Patient eligible to systemic treatment as Atopic Dermatitis Control Tool (ADCT) more than or equal to (≥) 7 and/or use topical corticosteroids (TCS) more than (\>) 90 gram (g)/month and/or TCS are not advisable. or 2. Patient currently under systemic treatment. * Able to understand and complete study-related questionnaires. Exclusion Criteria: * Any condition that, in the opinion of the Investigator, may interfere with patient's ability to participate in the study, such as short life expectancy, substance abuse, severe cognitive impairment, or other comorbidities that can predictably prevent the patient from adequately completing, as per routine care, the schedule of visits and assessments * Patient receiving systemic therapy only for a disease other than AD. * Patient participating in any interventional clinical trial at the time of enrolment. * Patient is under tutorship or curatorship; patient under safeguard of justice or deprived of his/her liberty by an administrative or court decision The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atopic dermatitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
62 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Investigational Site Number: 2500001
RECRUITINGLe Mans, 72037, France
-
Investigational Site Number: 2500003
RECRUITINGLimoges, 87042, France
-
Investigational Site Number: 2500004
RECRUITINGAngers, 49000, France
-
Investigational Site Number: 2500005
RECRUITINGParis, 75009, France
-
Investigational Site Number: 2500008
RECRUITINGSaint-Maur-dès-Faussés, 94100, France
-
Investigational Site Number: 2500009
RECRUITINGParis, 75020, France
-
Investigational Site Number: 2500010
RECRUITINGDunkirk, 59385, France
-
Investigational Site Number: 2500011
RECRUITINGLa Roche-sur-Yon, 85925, France
-
Investigational Site Number: 2500012
RECRUITINGLe Puy-en-Velay, 43000, France
-
Investigational Site Number: 2500013
RECRUITINGChalon-sur-Saône, 71100, France
-
Investigational Site Number: 2500015
RECRUITINGToulouse, 31200, France
-
Investigational Site Number: 2500016
RECRUITINGTours, 37044, France
-
Investigational Site Number: 2500017
RECRUITINGAngers, 49100, France
-
Investigational Site Number: 2500018
RECRUITINGCherbourg, 50102, France
-
Investigational Site Number: 2500019
RECRUITINGSainte-Maxime, 83120, France
-
Investigational Site Number: 2500020
RECRUITINGCholet, 49300, France
-
Investigational Site Number: 2500021
RECRUITINGRomans-sur-Isère, 26102, France
-
Investigational Site Number: 2500022
RECRUITINGRouen, 76031, France
-
Investigational Site Number: 2500023
RECRUITINGAmiens, 80000, France
-
Investigational Site Number: 2500024
RECRUITINGVillefranche-sur-Saône, 69655, France
-
Investigational Site Number: 2500025
RECRUITINGSaint-Etienne, 42100, France
-
Investigational Site Number: 2500026
RECRUITINGChalon-sur-Saône, 71100, France
-
Investigational Site Number: 2500027
RECRUITINGPérigueux, 24019, France
-
Investigational Site Number: 2500028
RECRUITINGPérigueux, 24000, France
-
Investigational Site Number: 2500029
RECRUITINGRennes, 35000, France
-
Investigational Site Number: 2500030
RECRUITINGParis, 75010, France
-
Investigational Site Number: 2500031
RECRUITINGLoperhet, 29470, France
-
Investigational Site Number: 2500032
RECRUITINGLa Ravoire, 73490, France
-
Investigational Site Number: 2500033
RECRUITINGNiort, 79021, France
-
Investigational Site Number: 2500034
RECRUITINGSaint-Maur-des-Fossés, 94100, France
-
Investigational Site Number: 2500035
RECRUITINGRennes, 35000, France
-
Investigational Site Number: 2500036
RECRUITINGBordeaux, 33000, France
-
Investigational Site Number: 2500037
RECRUITINGLa Tronche, 38700, France
-
Investigational Site Number: 2500038
RECRUITINGVannes, 56000, France
-
Investigational Site Number: 2500040
RECRUITINGBiarritz, 64200, France
-
Investigational Site Number: 2500041
RECRUITINGChâlons-en-Champagne, 51005, France
-
Investigational Site Number: 2500043
RECRUITINGBezannes, 51430, France
-
Investigational Site Number: 2500044
RECRUITINGLa Ravoire, 73490, France
-
Investigational Site Number: 2500045
RECRUITINGSaint-Quentin, 02321, France
-
Investigational Site Number: 2500046
RECRUITINGChalon-sur-Saône, 71100, France
-
Investigational Site Number: 2500047
RECRUITINGEstrées-Deniécourt, 80200, France
-
Investigational Site Number: 2500048
RECRUITINGClermond Ferrand, 63003, France
-
Investigational Site Number: 2500049
RECRUITINGFort-de-france, 97261, France
-
Investigational Site Number: 2500050
RECRUITINGArès, 33740, France
-
Investigational Site Number: 2500051
RECRUITINGAix-en-Provence, 13100, France
-
Investigational Site Number: 2500052
RECRUITINGVilleurbanne, 69100, France
-
Investigational Site Number: 2500053
RECRUITINGBordeaux, 33000, France
-
Investigational Site Number: 2500054
RECRUITINGBayonne, 64100, France
-
Investigational Site Number: 2500055
RECRUITINGMonaco, 98000, France
-
Investigational Site Number: 2500056
RECRUITINGLe Mans, 72000, France
-
Investigational Site Number: 2500057
RECRUITINGSainte-Eulalie, 15140, France
-
Investigational Site Number: 2500058
RECRUITINGMont-de-Marsan, 40024, France
-
Investigational Site Number: 2500059
RECRUITINGContamine-sur-Arve, 74130, France
-
Investigational Site Number: 2500060
RECRUITINGMarseille, 13012, France
-
Investigational Site Number: 2500062
RECRUITINGSaint-Gervais-les-Bains, 74170, France
-
Investigational Site Number: 2500063
RECRUITINGArès, 33740, France
-
Investigational Site Number: 2500065
RECRUITINGParis, 75005, France
-
Investigational Site Number: 2500066
RECRUITINGVilleurbanne, 69100, France
-
Investigational Site Number: 2500068
RECRUITINGLe Mans, 72000, France
-
Investigational Site Number: 2500070
RECRUITINGMont-Saint-Aignan, 76140, France
-
Investigational Site Number: 2500071
RECRUITINGParis, 75017, France
-
Investigational Site Number: 2500076
RECRUITINGSaint-Martin, 97150, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skin scans may predict who responds to dupilumab for eczema
- Can a daily liquid medicine calm severe eczema in toddlers and preschoolers?
- Scientists probe whether lebrikizumab rewires diseased skin at the molecular level
- Can a Lab-Made antibody calm severe eczema?
- Is your nose fueling infected eczema and scabies sores?
- Can an eczema drug reshape the Skin's microbial community?